AMZN
Amazon.com, Inc.
AMZN has the edge over IBP overall, supported by stronger valuation and stronger modeled upside.
IBP
Installed Building Products, Inc.
IBP trails on the overall score without a compensating advantage in the available component scores.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
IBP Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Healthy |
IBP's profitability and balance sheet are currently healthy, and its revenue and cash flow are stable.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over IBP in the historical PE scenario, which offers more potential upside but is not a forecast.
IBP PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 17x | $151 | -33% |
| Fair | 24x | $214 | -4.3% |
| Forward | 24x | $224 | — |
| Current | 26x | $224 | — |
| Expensive | 33x | $292 | +31% |
Historical ranges are pointers, not guarantees.
IBP's PE is in its fair range at 26x. On analysts' estimates for next year's earnings, today's price would be 24x.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
IBP Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Decline | |
| Stable | |
| Weakening | |
| Limited | |
| Moderate |
Analysts expect IBP's earnings and profitability to decline, with its revenue holding steady.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over IBP on earnings, with more consistent year-over-year improvement.
IBP Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.38 | +6.9% |
| Q3 2026 | $8.77 | -5.6% |
| Q2 2026 | $9.27 | +3.1% |
| Q1 2026 | $9.36 | +6.7% |
| Q4 2025 | $9.71 | +6.7% |
| Q3 2025 | $9.29 | +3.2% |
| Q2 2025 | $8.99 | +0.3% |
| Q1 2025 | $8.77 | -0.8% |
| Q4 2024 | $9.10 | +5.7% |
IBP earned $8.77 per share over the past year, down 5.6% from the year before.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over IBP on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over IBP on profitability, with a higher operating margin.
IBP Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $808.4M | +3.9% |
| Q2 2026 | $777.8M | +2.3% |
| Q1 2026 | $660.5M | -3.5% |
| Q4 2025 | $747.5M | -0.4% |
| Q3 2025 | $778.2M | +2.3% |
| Q2 2025 | $760.3M | +3.1% |
| Q1 2025 | $684.8M | -1.2% |
| Q4 2024 | $750.2M | +4.1% |
IBP's revenue grew through 2023 and has held roughly level since: $808M last quarter, up 3.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 11% | -2.4 points |
| Q2 2026 | 12% | -1.1 points |
| Q1 2026 | 8.7% | -1.5 points |
| Q4 2025 | 15% | +1.4 points |
| Q3 2025 | 14% | +0.4 points |
| Q2 2025 | 13% | +0.4 points |
| Q1 2025 | 10% | -2.5 points |
| Q4 2024 | 13% | -0.4 points |
IBP's operating margin was 11% last quarter, down 2.4 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
IBP Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $58.3M | -44% |
| Q2 2026 | $51.9M | -31% |
| Q1 2026 | $85.7M | +19% |
| Q4 2025 | $49.3M | -6.8% |
| Q3 2025 | $104.8M | +36% |
| Q2 2025 | $74.8M | +29% |
| Q1 2025 | $71.9M | +14% |
| Q4 2024 | $52.9M | -29% |
IBP has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
IBP Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -206K shares |
| 1 year | -2.5% | -666K shares |
| 3 years | -6.4% | -1.8M shares |
| 5 years | -11% | -3.1M shares |
| Available history | -11% | -3.4M shares |
IBP has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $76.3M |
| Q1 2026 | $25.4M |
| Q4 2025 | $37.7M |
| Q3 2025 | $51.4M |
| Q2 2025 | $49.2M |
| Q1 2025 | $34.3M |
| Q4 2024 | $78.9M |
IBP spent $139M buying back its own shares over the past year, down 35% from the year before.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN has the edge over IBP on leverage, with a lower net debt burden relative to earnings.
IBP Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.5x | Healthy |
| Q2 2026 | 1.6x | Healthy |
| Q1 2026 | 1.4x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 1.3x | Healthy |
| Q1 2025 | 1.4x | Healthy |
| Q4 2024 | 1.3x | Healthy |
IBP's net debt is about 1.5 years of its operating earnings (EBITDA), up from 1.3 years a year ago.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
IBP Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 50.4 | Neutral |
| Stochastic | 55.5 | Neutral |
IBP's weekly RSI is 50 (neutral) and its Stochastic is 55 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN has the edge over IBP on valuation relative to its sector.
IBP PE vs Consumer Cyclical Sector
| Metric | IBP | Sector median | Relative |
|---|---|---|---|
| PE | 26x | 18x | 42% above |
| PE % | 52 | 47 | 5 pts above |
IBP is trading at 26x earnings, a 42% premium to the Consumer Cyclical sector's median of 18x.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over IBP on trend strength, trading above more of its moving averages.
IBP Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $202.6 | 10% above |
| 20 week MA | $218.5 | 2.4% above |
| 50 week MA | $249.9 | 10% below |
| 100 week MA | $227.4 | 1.6% below |
| 200 week MA | $201.6 | 11% above |
IBP's trend is mixed: it's above three of its five weekly moving averages, and 11% above its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over IBP on returns for 2026, with the stronger performance.
IBP Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $69.1 | $108.7 | +57% |
| 2021 | $108.7 | $139.0 | +28% |
| 2022 | $139.0 | $87.5 | -37% |
| 2023 | $87.5 | $182.8 | +109% |
| 2024 | $182.8 | $174.3 | -4.6% |
| 2025 | $174.3 | $267.2 | +53% |
| 2026 YTD | $267.2 | $223.8 | -16% |
IBP has finished higher in four of the last six years, three of them by more than 50%. It's down 16% so far in 2026.